5163.0 HIV Vaccine and Treatment Issues

Wednesday, November 10, 2010: 12:30 PM - 2:00 PM
The purpose of this session is to explore factors related to HIV vaccine and treatment issues. Presentations will explore the factors associated with successful treatment and management of interventions for specific populations and treatment interventions to improve health outcomes among individuals with HIV, and challenges that continue to face treatment efforts. This session provides the opportunity to understand issues related to vaccine development and research in the context of the epidemic today. Participants will have opportunities to discuss both primary and secondary prevention related to vaccine and treatment.
Session Objectives: Evaluate current HIV vaccine efforts Describe factors related to treatment success
Scott Rhodes, PhD, MPH, CHES

Physical Activity Reduces Risk Factors for Cardiovascular Disease in HIV-infected Individuals
Gregory A. Hand, PhD MPH, Jason R. Jaggers, MS, Wesley D. Dudgeon, PhD, CSCS, Stephanie Burgess, PhD, J. Larry Durstine, PhD, G. William Lyerly, MS, PhD and Kenneth D. Phillips, PhD, RN
Peer-driven intervention increases rates of screening for AIDS clinical trials among persons living with HIV/AIDS from racial/ethnic minority backgrounds
Marya Gwadz, PhD, Noelle Leonard, PhD, Angela Banfield, MPH, Pablo Colon, DPM, DeShannon Bowens, MA, Marion Riedel, PhD, Amanda Ritchie, MAA, Charles Cleland, PhD and Donna Mildvan, MD

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: HIV/AIDS
Endorsed by: Social Work

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)

See more of: HIV/AIDS